Publikationen (94) Publikationen von BORJA GARCÍA BUENO

2024

  1. Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis

    Journal of Psychiatric Research, Vol. 172, pp. 334-339

  2. Bacterial lipopolysaccharide forms aggregates with apolipoproteins in male and female rat brains after ethanol binges

    Journal of Lipid Research, Vol. 65, Núm. 3

  3. Differential regulation of innate immune system in frontal cortex and hippocampus in a "double-hit" neurodevelopmental model in rats

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, Vol. 21, Núm. 1, pp. e00300

2023

  1. Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up

    International Journal of Neuropsychopharmacology, Vol. 26, Núm. 11, pp. 796-807

  2. Editorial: Neuroinflammatory and oxidative/nitrosative pathways in neuropsychiatric and neurological diseases and their possible neuropharmacological regulation, Volume II

    Frontiers in Pharmacology

  3. Immune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm?

    International Journal of Molecular Sciences, Vol. 24, Núm. 16

  4. Neuroinflammation related to the blood–brain barrier and sphingosine-1-phosphate in a pre-clinical model of periodontal diseases and depression in rats

    Journal of Clinical Periodontology, Vol. 50, Núm. 5, pp. 642-656

2022

  1. CCL2 Inhibition of Pro-Resolving Mediators Potentiates Neuroinflammation in Astrocytes

    International journal of molecular sciences, Vol. 23, Núm. 6

  2. Disinhibition-Like Behavior Correlates with Frontal Cortex Damage in an Animal Model of Chronic Alcohol Consumption and Thiamine Deficiency

    Biomedicines, Vol. 10, Núm. 2

  3. Editorial: Neuroinflammatory and oxidative/nitrosative pathways in neuropsychiatric and neurological diseases and their possible neuropharmacological regulation, volume I

    Frontiers in Pharmacology

  4. Lipid nanoparticles for antisense oligonucleotide gene interference into brain border-associated macrophages

    Frontiers in Molecular Biosciences, Vol. 9

  5. Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target

    International Journal of Molecular Sciences, Vol. 23, Núm. 11

  6. Sphk2 deletion is involved in structural abnormalities and Th17 response but does not aggravate colon inflammation induced by sub-chronic stress

    Scientific Reports, Vol. 12, Núm. 1

  7. The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance

    The international journal of neuropsychopharmacology, Vol. 25, Núm. 8, pp. 666-677

  8. The Role of the Oral Microbiota Related to Periodontal Diseases in Anxiety, Mood and Trauma- and Stress-Related Disorders

    Frontiers in Psychiatry, Vol. 12

2021

  1. Analysis of molecular networks in the cerebellum in chronic schizophrenia: Modulation by early postnatal life stressors in murine models

    International Journal of Molecular Sciences, Vol. 22, Núm. 18

  2. Cerebellar and cortical TLR4 activation and behavioral impairments in Wernicke-Korsakoff Syndrome: Pharmacological effects of oleoylethanolamide

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 108

  3. Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology

    Journal of Neuroinflammation, Vol. 18, Núm. 1

  4. Microglial CX3CR1 production increases in Alzheimer's disease and is regulated by noradrenaline

    GLIA, Vol. 69, Núm. 1, pp. 73-90

  5. Neuroinflammation and depression

    The Neuroscience of Depression: Features, Diagnosis, and Treatment (Elsevier), pp. 131-142